Afya Limited Class A AFYA

BELO HORIZONTE, Brazil, September 24, 2026--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), announced today that it has entered into a binding merger agreement with Yduqs Participações S.A. (B3: YDUQ3) ("Yduqs" and, together with Afya, the "Companies") providing for a business combination of the two companies (the "Proposed Transaction").

BELO HORIZONTE, Brazil, September 18, 2026--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, today announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized the increase of 17 medical seats of ITPAC Cruzeiro do Sul – Instituto Tocantinense Presidente Antonio Carlos Porto S.A. ("AFYA Cruzeiro do Sul"), in the city of Cruzeiro

AGCO, AFYA and ASEKY have been added to the Zacks Rank #5 (Strong Sell) List on September 2, 2026.

AFYA, APTV and CVCO have been added to the Zacks Rank #5 (Strong Sell) List on August 26th, 2026.

BELO HORIZONTE, Brazil, August 24, 2026--Afya Limited, or "Afya" (Nasdaq: AFYA) announced today that discussions with Yduqs Participações S.A. (B3: YDUQ3) ("Yduqs") regarding a potential business combination involving the two companies are at an early stage, following the material fact disclosed by Yduqs on this date, pursuant to Article 157, Paragraph 4 of Brazilian Law No. 6,404/1976 and CVM Resolution No. 44/2021.

Afya stock has delivered a decline of nearly 30% over the past five years, yet its current valuation checks and market multiples now point to a company that looks cheap rather than expensive. Afya shares are down 29.9% over the last five years, which puts a lot of past disappointment into the current US$13.88 price. The key support for any re rating can come from how reliably Afya converts its education revenues into cash and maintains margins, while a setback in enrollment growth or higher...

Afya Ltd (AFYA) reports 7% revenue growth in H1 2026, returning 106% of free cash flow to shareholders while navigating margin contraction and regulatory shifts.

Moby summary of Afya Limited's Q2 2026 earnings call

BELO HORIZONTE, Brazil, August 13, 2026--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, reported today its financial and operating results for the three and six-month period, which ended June 30, 2026 (second quarter 2026). Financial results are expressed in Brazilian Reais and are presented in accordance with International Financial Reporting Standards ("IFRS").

BELO HORIZONTE, Brazil, July 29, 2026--Afya Limited (Nasdaq: AFYA; B3: A2FY34) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that Marcelo Ken Suhara was appointed, on July 27, 2026, as Chair Member of its Audit, Risks and Ethics Committee.

Investors need to pay close attention to AFYA stock based on the movements in the options market lately.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.